GlassScriptPhysician profile
Allen B Davis
NPI 1861429003
$1,183.91
in general payments reported to CMS, 2019-2025
13 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $11.01 · 2021: $393 · 2022: $97.21 · 2023: $162 · 2024: $232 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $449.22 | 2019-2023 | Puraply |
| Misonix INC | $145.46 | 2021 | |
| Endologix LLC | $136.58 | 2025 | |
| Smith+Nephew, INC. | $118.23 | 2019-2024 | Collagenase Santyl, Pico, Renasys Go V2 Home |
| Silk Road Medical, INC. | $107.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Solventum Corporation | $55.35 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, Activ.A.C. Ion Progress |
| Kci USA, INC. | $44.54 | 2022-2023 | Activ.A.C., V.A.C. Dermatac |
| Pfizer INC. | $36.59 | 2023 | |
| Derma Sciences, INC. | $24.44 | 2019 | |
| Advanced Oxygen Therapy INC. | $23.79 | 2024 | Topical Oxygen Chamber For Extremities |
| Medline Industries LP | $19.38 | 2021 | |
| Tactile Systems Technology INC | $12.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.